2020 ROSENMAN INNOVATORS

Corporate award recognition for Avisi Technologies as a selected company in the 2020 Rosenman Innovators program.

Avisi Technologies is developing VisiPlate to treat glaucoma, the world’s leading cause of irreversible blindness. VisiPlate is a nanotechnology-enabled ocular implant for treating glaucoma more safely and effectively.

Share this article:
FacebookXLinkedIn
コンテンツへスキップ